LifeMD Appoints Dr. Calum MacRae to its Board of Directors [Yahoo! Finance]
LifeMD, Inc. (LFMD)
Company Research
Source: Yahoo! Finance
appointment of Calum MacRae, M.D., Ph.D., a clinician, researcher and educator at Harvard Medical School, as an independent member of its Board of Directors. “We are delighted to welcome Dr. MacRae to the LifeMD Board of Directors. He brings deep experience in cardiology, internal medicine and clinical innovation, with a focus on disease management and the implementation of novel solutions to improve the delivery of virtual healthcare services,” said Justin Schreiber, Chairman and Chief Executive Officer of LifeMD. “Aside from being a world-renowned clinician, we are particularly excited to leverage Dr. MacRae's experience with systematic approaches to the management of chronic disease, which includes leveraging novel in-home tools and labs that can transform the way chronic and preventative care are delivered.” “I am impressed by LifeMD's strategy and track record of providing innovative and quality virtual care to its patients,” said Dr. MacRae. “I look forward to working closel
Show less
Read more
Impact Snapshot
Event Time:
LFMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFMD alerts
High impacting LifeMD, Inc. news events
Weekly update
A roundup of the hottest topics
LFMD
News
- LifeMD, Inc. (NASDAQ: LFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.MarketBeat
- LifeMD First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]Yahoo! Finance
- LifeMD, Inc. (NASDAQ:LFMD) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- LifeMD, Inc. (NASDAQ: LFMD) had its price target raised by analysts at Cantor Fitzgerald from $13.00 to $15.00. They now have an "overweight" rating on the stock.MarketBeat
- LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue GuidanceGlobeNewswire
LFMD
Earnings
- 5/8/24 - Beat
LFMD
Sec Filings
- 5/8/24 - Form 10-Q
- 5/2/24 - Form 8-K
- 4/29/24 - Form ARS
- LFMD's page on the SEC website